Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 1999

Evaluation of late cardiotoxicity after anthracycline therapy in children with neoplastic disease

Andrzej Kurylak, Krystyna Graduszewska-Czerebiej, Mariola Osińska-Kró—lak, Mariusz Wysocki, Michał Kołodziejczak, Danuta Kurylak, Anna Balcar-Boroń

Med Sci Monit 1999; 5(1): CR98-102 :: ID: 505265


The work is devoted to the evaluation of late cardiotoxicity as well as current status of circulatory system in patients with neoplastic disease who received anthracycline apart from other cytostatic agents during chemotherapy, without prophylactic protection of cardioprotective drugs. The material consists of 34 children after completed anti-neoplastic treatment. Presently, the patients' age ranges between 9 and 19 years. Anti-neoplastic therapy in these children has been completed for 40-99 months. During chemotherapy, anthracycline preparations were used in the total dose of 180-540 mg/m2. Some patients demonstrated cardiotoxic effect without clinical symptoms, which was independent of the cumulative dose of anthracycline. It manifested itself in the changes in electrocardiographic record (QT prolongation), as well as the decrease of left ventricular circumferential shortening fraction by 5% or more in echocardiographic examination when compared to the values observed before treatment. Therefore, further observation of patients with electro- or echocardiographic anomalies is necessary in order to exclude myocardial damage.

Keywords: cardiotoxicity, Anthracyclines, neoplastic diseases

Add Comment 0 Comments

571 0


01 December 2023 : Editorial  

Editorial: Outbreaks of Post-Pandemic Childhood Pneumonia and the Re-Emergence of Endemic Respiratory Infections

Dinah V. Parums

DOI: 10.12659/MSM.943312

Med Sci Monit 2023; 29:e943312


In Press

04 Dec 2023 : Animal Research  

Effects of Intrathecal Ketamine on Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor and Mech...

Med Sci Monit In Press; DOI:  

01 Dec 2023 : Clinical Research  

Risk Factors and Clinical Outcomes of COVID-19 Infection in Multiple Sclerosis Patients: A Retrospective St...

Med Sci Monit In Press; DOI:  

30 Nov 2023 : Review article  

Decoding the Neurological Sequelae of General Anesthesia: A Review

Med Sci Monit In Press; DOI:  

30 Nov 2023 : Clinical Research  

Enhanced Pain Relief and Muscle Growth in Individuals with Low Back Instability: The Impact of Blood Flow R...

Med Sci Monit In Press; DOI:  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750